Cochrane Eyes and Vision Group (CEVG).
This is a new column for reviews from the Cochrane Eyes and Vision Group (CEVG). Its main aim is to promote access to systematic reviews of all the interventions used to prevent or treat eye diseases. It is based at the London School of Hygiene & Tropical Medicine in London, UK, and Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland, USA.
West of England Eye Unit, Royal Devon & Exeter Hospital, Barrack Road, Exeter EX2 5DW, UK. eyapyc@gmail.com
Y C
YC
Yap
S
S
Fraser
R
R
Wormald
D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D053685:Laser Therapy; D008268:Macular Degeneration / Q000188:drug therapy*; D015594:Optic Disk Drusen / Q000628:therapy*; D012163:Retinal Detachment / Q000473:pathology / Q000517:prevention & control* / Q000628:therapy; D014130:Trabeculectomy / Q000379:methods*
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors